Annual Current Assets
$788.95 M
+$22.62 M+2.95%
December 31, 2024
Summary
- As of March 10, 2025, APLS annual total current assets is $788.95 million, with the most recent change of +$22.62 million (+2.95%) on December 31, 2024.
- During the last 3 years, APLS annual current assets has fallen by -$35.09 million (-4.26%).
- APLS annual current assets is now -13.98% below its all-time high of $917.19 million, reached on December 31, 2020.
Performance
APLS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$788.95 M
-$44.94 M-5.39%
December 31, 2024
Summary
- As of March 10, 2025, APLS quarterly total current assets is $788.95 million, with the most recent change of -$44.94 million (-5.39%) on December 31, 2024.
- Over the past year, APLS quarterly current assets has stayed the same.
- APLS quarterly current assets is now -28.54% below its all-time high of $1.10 billion, reached on March 31, 2022.
Performance
APLS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
APLS Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.0% | 0.0% |
| 3 y3 years | -4.3% | -4.3% |
| 5 y5 years | +111.5% | -4.3% |
APLS Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.3% | +9.7% | -28.5% | +9.7% |
| 5 y | 5-year | -14.0% | +111.5% | -28.5% | +111.5% |
| alltime | all time | -14.0% | >+9999.0% | -28.5% | +5713.3% |
Apellis Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $96.10 M(+329.0%) | $788.95 M(-5.4%) |
| Sep 2024 | - | $833.90 M(-3.0%) |
| Jun 2024 | - | $859.97 M(+6.0%) |
| Mar 2024 | - | $811.43 M(+5.9%) |
| Dec 2023 | $22.40 M(-45.0%) | $766.33 M(-3.8%) |
| Sep 2023 | - | $796.77 M(-10.7%) |
| Jun 2023 | - | $892.69 M(-6.5%) |
| Mar 2023 | - | $954.25 M(+32.6%) |
| Dec 2022 | $40.69 M(-29.5%) | $719.52 M(-13.5%) |
| Sep 2022 | - | $831.94 M(-13.3%) |
| Jun 2022 | - | $959.97 M(-13.0%) |
| Mar 2022 | - | $1.10 B(+34.0%) |
| Dec 2021 | $57.72 M(+33.1%) | $824.05 M(+73.3%) |
| Sep 2021 | - | $475.43 M(-27.4%) |
| Jun 2021 | - | $655.13 M(-15.3%) |
| Mar 2021 | - | $773.63 M(-15.7%) |
| Dec 2020 | $43.38 M | $917.19 M(+23.6%) |
| Sep 2020 | - | $742.35 M(-13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $853.83 M(+27.0%) |
| Mar 2020 | - | $672.41 M(+80.2%) |
| Dec 2019 | $16.15 M(+1375.8%) | $373.10 M(-17.3%) |
| Sep 2019 | - | $451.19 M(+46.3%) |
| Jun 2019 | - | $308.41 M(-0.7%) |
| Mar 2019 | - | $310.53 M(+53.4%) |
| Dec 2018 | $1.09 M(+841.7%) | $202.44 M(-15.3%) |
| Sep 2018 | - | $238.93 M(-10.4%) |
| Jun 2018 | - | $266.70 M(+63.5%) |
| Mar 2018 | - | $163.09 M(-10.4%) |
| Dec 2017 | $116.20 K(+80.2%) | $182.02 M(+856.3%) |
| Sep 2017 | - | $19.03 M(-66.4%) |
| Jun 2017 | - | $56.57 M(+106.7%) |
| Dec 2016 | $64.50 K(-51.6%) | $27.37 M(-28.1%) |
| Dec 2015 | $133.30 K(+126.3%) | $38.04 M(+180.3%) |
| Sep 2015 | - | $13.57 M(-18.8%) |
| Jun 2015 | - | $16.71 M(+17.3%) |
| Dec 2014 | $58.90 K(+547.3%) | $14.25 M |
| Dec 2013 | $9100.00 | - |
FAQ
- What is Apellis Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual current assets year-on-year change?
- What is Apellis Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly current assets year-on-year change?
What is Apellis Pharmaceuticals annual total current assets?
The current annual current assets of APLS is $788.95 M
What is the all time high annual current assets for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total current assets is $917.19 M
What is Apellis Pharmaceuticals annual current assets year-on-year change?
Over the past year, APLS annual total current assets has changed by +$22.62 M (+2.95%)
What is Apellis Pharmaceuticals quarterly total current assets?
The current quarterly current assets of APLS is $788.95 M
What is the all time high quarterly current assets for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total current assets is $1.10 B
What is Apellis Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, APLS quarterly total current assets has changed by $0.00 (0.00%)